NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Nuformix plc (LSE: NFX)
NFX Technical Analysis
5
As on 25th Nov 2024 NFX STOCK Price closed @ 0.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.27 & Strong Sell for SHORT-TERM with Stoploss of 0.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NFXSTOCK Price
Open | 0.04 | Change | Price | % |
High | 0.06 | 1 Day | 0.00 | 0.00 |
Low | 0.04 | 1 Week | 0.00 | 0.00 |
Close | 0.05 | 1 Month | -0.01 | -16.67 |
Volume | 211119350 | 1 Year | -0.23 | -82.14 |
52 Week High 0.40 | 52 Week Low 0.05 |
LSE UK Most Active Stocks
CPX | 0.17 | 21.43% |
TRP | 0.03 | % |
UKOG | 0.02 | 0.00% |
LLOY | 54.66 | 0.44% |
MSMN | 0.04 | 0.00% |
BZT | 0.03 | 0.00% |
NFX | 0.05 | 0.00% |
DKE | 0.15 | 0.00% |
NNN | 0.09 | 50.00% |
SYME | 0.00 | % |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
NFX Daily Charts |
NFX Intraday Charts |
Whats New @ Bazaartrend |
NFX Free Analysis |
|
NFX Important Levels Intraday
RESISTANCE | 0.09 |
RESISTANCE | 0.08 |
RESISTANCE | 0.07 |
RESISTANCE | 0.06 |
SUPPORT | 0.04 |
SUPPORT | 0.03 |
SUPPORT | 0.02 |
SUPPORT | 0.01 |
NFX Forecast November 2024
4th UP Forecast | 0.22 |
3rd UP Forecast | 0.17 |
2nd UP Forecast | 0.13 |
1st UP Forecast | 0.1 |
1st DOWN Forecast | 0 |
2nd DOWN Forecast | -0.03 |
3rd DOWN Forecast | -0.07 |
4th DOWN Forecast | -0.12 |
NFX Weekly Forecast
4th UP Forecast | 0.20 |
3rd UP Forecast | 0.15 |
2nd UP Forecast | 0.12 |
1st UP Forecast | 0.09 |
1st DOWN Forecast | 0.01 |
2nd DOWN Forecast | -0.02 |
3rd DOWN Forecast | -0.05 |
4th DOWN Forecast | -0.10 |
NFX Forecast2024
4th UP Forecast | 0.82 |
3rd UP Forecast | 0.57 |
2nd UP Forecast | 0.42 |
1st UP Forecast | 0.27 |
1st DOWN Forecast | -0.17 |
2nd DOWN Forecast | -0.32 |
3rd DOWN Forecast | -0.47 |
4th DOWN Forecast | -0.72 |
Nuformix plc ( LSE UK Symbol : NFX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NFX Other Details
Segment | EQ | |
Market Capital | 7335952.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
NFX Address
NFX Latest News
NFX Business Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. Its lead programs include NXP001, which is in Phase 1-ready stage for oncology supportive care; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. The company is also developing NXP004, which is in the research Phase for treating oncology. It also has an option agreement with Oxilio Ltd. for developing and exploiting NXP001 for the treatment of cancer. Nuformix plc was founded in 2008 and is based in London, the United Kingdom. Address: 60 Gracechurch Street, London, United Kingdom, EC3V 0HR
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service